
ARFXF
Healthcare · Biotechnology · $44.0M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 13, 2022 | Before the open | — | -0.01 | — |
| Mar 17, 2022 | After the close | — | -0.01 | — |
| Nov 12, 2021 | Before the open | — | -0.00 | — |
| Aug 12, 2021 | Before the open | — | -0.00 | — |
| May 14, 2021 | Before the open | — | -0.00 | — |
| Mar 31, 2021 | Before the open | — | -0.02 | — |
| Nov 11, 2020 | Before the open | -0.01 | -0.01 | 0.0% |
| Aug 13, 2020 | Before the open | -0.01 | -0.01 | 0.0% |
| May 13, 2020 | Before the open | — | -0.01 | — |
| Mar 18, 2020 | Before the open | -0.01 | -0.01 | 0.0% |
| Nov 14, 2019 | Before the open | -0.01 | -0.01 | 0.0% |
| Aug 13, 2019 | Before the open | -0.01 | -0.01 | 0.0% |
| May 14, 2019 | Before the open | -0.01 | -0.01 | 0.0% |
| Mar 15, 2019 |
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the…
| Before the open |
| -0.01 |
| -0.01 |
| 0.0% |
| Nov 13, 2018 | Before the open | -0.01 | -0.01 | 0.0% |
| Aug 14, 2018 | Before the open | -0.01 | -0.01 | 0.0% |
| May 11, 2018 | Before the open | -0.01 | -0.01 | 0.0% |
| Mar 14, 2018 | Before the open | -0.01 | -0.01 | 0.0% |